0.00Open0.00Pre Close0 Volume0 Open Interest38.00Strike Price0.00Turnover0.00%IV87.28%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma40.58Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Celldex Therapeutics Stock Discussion
New Clinical Data Reveals Breakthrough Potential for Celldex's EoE Treatment at Major Medical Conference
Can Celldex's Dual-Mechanism CDX-622 Transform Inflammatory Disease Treatment?
Can Celldex's Urticaria Treatment Transform Patient Lives? Phase 2 Data Shows 95% Quality of Life Improvement
$Arrowhead Pharmaceuticals (ARWR.US)$ - Alpha Early Alert 🚨 H&S 📈🎯🚀🥇 (45.00) is on the Table 🫵🏻💪🏻🥇 Find the Apex and win!
• $Cytokinetics (CYTK.US)$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng (XPEV.US)$ +3.4% (June deliveries)
• $NIO Inc (NIO.US)$ +2.9% (June deliveries)
• $Bitfarms (BITF.US)$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(Delisted) (ACCD.US)$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals (BCRX.US)$ +2.6% (presents new data demonstrating...
No comment yet